TMC207 is a first-in-class anti-TB diarylquinoline (also named R207910 ... culture were 48% (vs 9% in the placebo group) at 8 weeks' treatment with TMC207 on top of a standard backbone in a ...

Background: Patients on anti-tuberculosis treatment may develop acute kidney injury (AKI), but little is known about the renal outcome and prognostic factors, especially in an aging population.

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) treatments by helping infected cells die a gentler death, Johns Hopkins ...

The patient was given anti-TB meds two months after mistakenly receiving the vaccine. "The initial treatment was effective, and she recovered fully and reported no further symptoms six months ...

An experimental drug now in clinical trials as a cancer treatment could help boost the power of first-line tuberculosis (TB) ...

“In the modern era, we have the accurate diagnostic tests and effective anti-TB drugs to reduce TB to a historical anecdote,” Schaffner said. “If we have the determination and provide the re ...

European tuberculosis surveillance report underscores the gravity of the situation in the WHO European region.1 Across 53 member states in Europe and Central Asia, more than 225 000 people had ...

98,101 persons with TB-like symptoms have found 5,588 new TB cases in the State, whose treatment and follow-up is being ensured, according to the State TB Division. The 100-day intensive campaign ...

The Uttar Pradesh government''s campaign to make the state Tuberculosis free by the end of 2025 is yielding results as so far, 8,563 gram panchayats in the state have become TB free, official sources ...